Technical Analysis for ENLV - Enlivex Therapeutics Ltd.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Stochastic Buy Signal | Bullish | 0.00% | |
Lower Bollinger Band Walk | Weakness | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Lower Bollinger Band Walk | Weakness | 0.74% | |
Below Lower BB | Weakness | 0.74% | |
Down 3 Days in a Row | Weakness | 0.74% | |
Lower Bollinger Band Touch | Weakness | 0.74% | |
Oversold Stochastic | Weakness | 0.74% |
Alert | Time |
---|---|
Possible Inside Day | about 20 hours ago |
Down 3% | about 23 hours ago |
Up 3% | about 23 hours ago |
Fell Below Lower Bollinger Band | about 23 hours ago |
Down 2 % | about 23 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 09/09/2024
Enlivex is a clinical stage immunotherapy company, developing an allogeneic drug pipeline for immune system rebalancing. Immune system rebalancing is critical for the treatment of life-threatening immune and inflammatory conditions which involve hyper-expression of cytokines (Cytokine Release Syndrome) and for which there are no approved treatments (unmet medical needs), as well as solid tumors immune-checkpoint rebalancing.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Immunology Solid Tumors Immune System Immunotherapy Cancer Treatment Tumor Virotherapy Coronavirus Cytokine Inflammatory Conditions
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Immunology Solid Tumors Immune System Immunotherapy Cancer Treatment Tumor Virotherapy Coronavirus Cytokine Inflammatory Conditions
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 4.59 |
52 Week Low | 1.15 |
Average Volume | 129,884 |
200-Day Moving Average | 1.98 |
50-Day Moving Average | 1.45 |
20-Day Moving Average | 1.49 |
10-Day Moving Average | 1.45 |
Average True Range | 0.13 |
RSI (14) | 40.12 |
ADX | 17.56 |
+DI | 13.32 |
-DI | 18.60 |
Chandelier Exit (Long, 3 ATRs) | 1.36 |
Chandelier Exit (Short, 3 ATRs) | 1.66 |
Upper Bollinger Bands | 1.65 |
Lower Bollinger Band | 1.33 |
Percent B (%b) | 0.09 |
BandWidth | 21.33 |
MACD Line | -0.03 |
MACD Signal Line | 0.00 |
MACD Histogram | -0.0254 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.52 | ||||
Resistance 3 (R3) | 1.52 | 1.46 | 1.49 | ||
Resistance 2 (R2) | 1.46 | 1.42 | 1.46 | 1.48 | |
Resistance 1 (R1) | 1.41 | 1.40 | 1.44 | 1.41 | 1.47 |
Pivot Point | 1.36 | 1.36 | 1.37 | 1.36 | 1.36 |
Support 1 (S1) | 1.30 | 1.31 | 1.33 | 1.31 | 1.25 |
Support 2 (S2) | 1.25 | 1.29 | 1.25 | 1.24 | |
Support 3 (S3) | 1.20 | 1.25 | 1.23 | ||
Support 4 (S4) | 1.20 |